Purpose: To report the identification and characterization of stromal amyloid deposits in patients with keratoconus.
A myloid is a term given to a variety of proteins that appear as amorphous, eosinophilic hyaline material on routine hematoxylin-eosin staining. When stained with Congo red and viewed with polarized light, amyloid exhibits a characteristic birefringence and red-green dichroism. Ultrastructurally, amyloid has a fibrillar appearance with the fibers ranging from 70 to 100 Å in diameter.
Amyloid deposition may be classified as primary or secondary, localized or systemic. Lattice and combined granular-lattice corneal dystrophies are autosomal dominant disorders that feature primary localized dystrophic corneal amyloid deposition. Missense mutations in the transforming growth factor beta-induced gene (TGFBI), which codes for a protein product known as TGFBIp, are associated with these corneal dystrophies, and the corneal deposits in these dystrophies contain TGFBIp. 1 More than 35 different pathogenic mutations have been identified in TGFBI, located in exons 4, 11, 12, 13, and 14. 2,3 In contrast, Meretoja syndrome, multiple myeloma, and familial cutaneous amyloidosis are associated with systemic amyloid deposition and are well-recognized causes of secondary corneal amyloidosis. [4] [5] [6] Secondary corneal amyloid deposition has also been associated with localized causes such as trachoma, trichiasis, interstitial keratitis, phlyctenular keratitis, and uveitis. [7] [8] [9] Despite the significant number of localized and systemic disorders that have been associated with corneal amyloid deposition, amyloid deposits have only been reported a few times in association with keratoconus, a relatively common corneal degeneration and frequent indication for corneal transplantation worldwide. [10] [11] [12] [13] Screening of TGFBI to exclude the most common dystrophic cause of corneal amyloid deposition was not performed in any of these previous reports. Additionally, neither a determination of the origin of the amyloid deposits nor a characterization of the deposits was performed. 13 In this report, we describe 2 cases of keratoconus associated with clinically unsuspected corneal amyloidosis. Histochemical, immunohistochemical, and molecular genetic analyses were performed as well to investigate the nature and origin of the amyloid deposits.
MATERIALS AND METHODS
The researchers followed the tenets of the Declaration of Helsinki in the treatment of the subjects reported in this study. Study approval was obtained from the Institutional Review Board at The University of California, Los Angeles (UCLA IRB # 94-07-243-24B).
Clinical Examination
Clinical examination of the patients included slit-lamp biomicroscopy and corneal topography. The diagnosis of keratoconus was based on the presence of characteristic topographic features, such as inferior or central corneal steepening or an asymmetric bow tie pattern with skewing of the radial axes, and the presence of 1 or more of the following characteristic clinical features in 1 or both eyes: conical corneal deformation, corneal stromal thinning, a Fleischer ring, or Vogt striae.
Histopathologic and Immunohistochemical Examination
The corneal buttons excised from the subjects at the time of penetrating keratoplasty were fixed in 10% neutral buffered formaldehyde. After embedding in paraffin, thin sections were stained with hematoxylin and eosin, Alcian blue, periodic acid-Schiff, Congo red, and Masson trichrome stains. Immunohistochemistry was performed on sections obtained from the right corneal button from case 1 using antibodies directed against prealbumin, lysozyme, kappa and lambda light chains, and TGFBIp. The antibody for TGFBIp was produced in goats immunized with purified, NSO-derived recombinant human transforming growth factor beta-induced gene H3(rhbIG-H3). Human bIGH-H3-specific immunoglobulin G was purified by human bIG-H3 affinity chromatography (R&D Systems, Minneapolis, MN). Normal goat immunoglobulin G (Jackson Laboratories, West Grove, PA) at the same concentration as the specific antibody was used as the negative antibody control. Immunohistochemical staining of slides prepared from the corneal button of an individual with a confirmed TGFBI dystrophy using the same antibody for TGFBIp was used as the positive control. 14 TGFBIp antibody binding was detected using an RTU Vectastain-HRP Kit (Vector Laboratories, Burlingame, CA).
DNA Collection and Analysis
Buccal epithelial swabs were collected from the patients using CytoSoft CP-5B brushes (Medical Packaging Corporation, Camarillo, CA). Genomic DNA was isolated from the buccal epithelial cells using the QIAamp DNA Mini Kit spin protocol (Qiagen, Valencia, CA). Polymerase chain reaction amplification and automated sequencing of exons 4, 11, 12, 13, and 14 of TGFBI were performed using previously described primer sequences and conditions. 15 Nucleotide sequences were compared with the published TGFBI complementary DNA sequence (GenBank accession no. NM_000358).
RESULTS

Case Histories Case 1
A 74-year-old man with a 40-year history of bilateral keratoconus was referred to one of the authors (J.D.H.) for combined penetrating keratoplasty and cataract extraction in the right eye. The patient had noticed increasingly poor rigid gas-permeable contact lens-corrected vision, which was attributed to corneal scarring. The patient's medical history was significant only for hypertension and coronary artery disease, and he denied a family history of keratoconus or other eye disorders.
On presentation, contact lens-corrected visual acuity was 20/80 in the right eye and 20/70 in the left eye. Both corneas demonstrated central conical deformation with apical stromal thinning and scarring, right eye more than left. No other stromal opacities were noted. A 4+ nuclear sclerotic cataract was present in each eye.
A combined penetrating keratoplasty and cataract extraction was performed in the left eye, followed 2 years later by a combined penetrating keratoplasty and cataract extraction in the right eye. Four months after surgery in the right eye, both corneal transplants were clear and compact, devoid of focal stromal deposits.
Case 2
A 37-year-old man with a 10-year history of bilateral keratoconus presented to one of the authors (R.C.) complaining of increasingly poor contact lens-corrected vision for the previous 2 years. The patient's medical history was significant for panhypopituitarism secondary to head trauma, hypertension, asthma, and acid reflux, but he denied a family history of keratoconus or other ocular disorders.
Contact lens-corrected visual acuities measured 20/25 in the right eye and 20/100 in the left eye. Significant central conical deformation and apical stromal thinning were noted in each cornea. Additionally, apical scarring was noted in each cornea, more prominent in the left eye than in the right. Topographic imaging of the left cornea revealed irregular central corneal steepening (simulated K readings were 67.91 diopters @ 125 degrees 3 58.70 diopters).
A penetrating keratoplasty was performed in the left eye, and the corneal button was submitted for histopathologic examination. Four months after the corneal transplant, the graft was clear without evidence of stromal deposits.
Histopathologic and Immunohistochemical Findings
Microscopic examination of the stained corneal sections from both cases revealed irregular epithelial surfaces with areas of epithelial thickening. Thickened and duplicated basement membrane and areas of irregular thinning and focal disruptions in Bowman layer were noted, consistent with keratoconus. The stroma demonstrated scar formation and central thinning. Central, amorphous, eosinophilic deposits, extending from the anterior stroma to the posterior two thirds of the stroma, were noted in each of the corneal buttons submitted from cases 1 and 2. The deposits did not stain with Alcian blue but appeared pink with periodic acid-Schiff and red with Masson trichrome and Congo red stains. The Congo red deposits demonstrated green birefringence and dichroism with crossed polarizing lenses. Descemet membrane and endothelium appeared unremarkable in each of the corneal buttons (Figs. 1, 2) .
Immunohistochemical staining of the right corneal button from case 1 did not reveal significant reactivity with antibodies for prealbumin, lysozyme, and kappa and lambda light chains. However, the Congo red-stained stromal deposits demonstrated positive reactivity with an antibody to TGFBIp (Fig. 3 ). Immunohistochemical staining of the corneal button from case 2 was not performed.
Genetic Screening
Screening of TGFBI exons 4, 11, 12, 13, and 14 in each patient revealed only 2 previously reported synonymous substitutions, both in the heterozygous state: c.1463C.T (p.Leu472Leu, rs1133170) and c.1667T.C (p.Phe540Phe, rs4669).
DISCUSSION
We identified stromal amyloid deposits associated with TGFBIp in the corneal buttons of 2 patients with keratoconus and excluded previously reported amyloidogenic and novel coding region mutations in TGFBI. This represents only the fourth report of corneal amyloidosis associated with keratoconus and is the first to characterize the nature of the amyloid protein as containing TGFBIp and to exclude a TFGBI mutation ( Table 1 ). McPherson et al 11 identified corneal amyloidosis as an incidental finding in 3.5% of 210 ocular pathology specimens (75 whole eyes and 135 corneal buttons), one of which was a corneal button collected from a patient with keratoconus. A subsequent examination of 17 corneal buttons from patients with keratoconus revealed amyloid deposits in 3 (17.6%). 10 The amyloid deposits were small in these patients and were scattered in various depths of the cornea, from just below Bowman layer to just above Descemet membrane. It was not noted in these reports whether corneal scarring was present, as was observed in the 2 corneal specimens that we report. Stern et al 13 reported a case of amyloidosis associated with keratoconus, in which a central gray-white opacity was noted in the anterior corneal stroma on clinical examination, and panstromal amyloid deposition was found on histopathologic analysis. The authors suggested that long-term use of hard contact lenses with significant central corneal touch could have contributed to the development of the central scarring and presumed amyloid deposition. Genetic analysis was not performed in any of these previously reported cases.
Various theories have been put forth to explain the mechanism of development of secondary localized corneal amyloidosis. In cases involving repeated local trauma to the corneal surface, such as in the setting of trichiasis, lactoferrin has been proposed to play a role in corneal amyloid formation. 15, 16 Suesskind et al 9 demonstrated corneal amyloid deposits in cases of Fuchs endothelial dystrophy that stained with antibodies to TGFBIp. The authors explained this observation by proposing that proteolysis, in association with certain environmental factors, may alter the structure of TGFBIp in such a way that it forms fibrils capable of aggregating into amyloid deposits. In this report, we also demonstrate the presence of TGFBIp in stromal amyloid deposits in a patient with a non-TGFBI corneal dystrophy, leading to the conclusion that TGFBIp aggregation in the corneal stroma may be found in both dystrophic and nondystrophic corneal disorders.
Although other investigators have looked for a possible relationship between TGFBI, TGFBIp, and keratoconus, no definitive association has been established. As TGFBIp has been proposed to play a role in corneal development, wound healing, and lamellar adhesion, investigators have theorized that mutations in TGFBI leading to decreased expression of TGFBIp in the corneal stroma could result in decreased mechanical stability of the cornea and contribute to the development of keratoconus. 17 Although levels of TGFBIp have been shown to be decreased in keratoconic corneas, 17 no mutations have been identified in TGFBI in affected individuals. 18 Paradoxically, other investigators have demonstrated elevated levels of TGFBIp in areas of corneal scarring, likely related to the stimulation of TGFBIp production by TGFB1. 19, 20 The current study raises important questions about the mechanism of amyloid formation in the cornea. Although it is clear that certain missense mutations in TGFBI lead to the development of a mutant TGFBIp in the form of amyloid fibrils, the current study demonstrates that such mutations are not mandatory. A number of other factors may be involved. The presence of amyloidogenic consensus sequences renders numerous proteins and peptides vulnerable to amyloid fibril formation. 21 TGFBIp contains amyloidogenic domains, and it is plausible that fibril formation could be initiated by alteration in TGFBIp expression, local pH, molecular chaperones, proteolysis, or even in the unfolded protein responseproteasomal pathway for removal of misfolded proteins. 22 Corneal injury, such as during keratorefractive surgery, may lead to a significant acceleration of amyloid formation through TGFB1-mediated upregulation of TGFBIp production by the injured keratocytes. [23] [24] [25] In the cases we report, local corneal injury that led to stromal scarring evident on clinical and histopathologic examination of the corneas may have also produced an increased expression of TGFB1, with subsequent increased expression of TGFBIp in the corneal stroma. Although the increased expression of the wild-type TGFBIp would not be expected to result in the formation of stromal amyloid deposits that are characteristic of mutant TGFBIp, it is possible that local factors in keratoconic corneas predispose to the development of the observed amyloid deposits in the absence of coding region mutations in TGFBI. 
